Bryan D. Cox
4Patents
0h-index
13Co-inventors
28Inventor score
Filing activity: May 15, 2015 → May 3, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12239655B2 | Combined modalities for nucleosides and/or NADPH oxidase (NOX) inhibitors as myeloid-specific antiviral agents | Chemistry; Metallurgy | 0 | Active |
| US11963972B2 | Antiviral agents and nucleoside analogs for treatment of Zika virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US12318393B2 | Modulators of orphan nuclear receptors for NASH and other metabolic disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US10450293B2 | Chemokine CXCR4 and CCR5 receptor modulators and uses related thereto | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.